What is a key goal of clinical trial monitoring?

The primary goal of clinical trial monitoring is to support compliance with study protocols and regulations. This critical aspect of clinical trials ensures that the study is being conducted as outlined in the trial protocol and adheres to all relevant laws and guidelines, such as Good Clinical Practice (GCP). Monitoring involves systematic observation and review of the various aspects of the trial, including enrollment of participants, data collection, and overall protocol adherence, thereby ensuring the integrity and reliability of the clinical trial results.

Ensuring compliance is vital not only for the validity of the trial but also for the safety and rights of the participants involved. Effective monitoring helps identify potential issues early on and facilitates timely interventions, reducing the risk of non-compliance and enhancing the reliability of the collected data. The focus on regulatory adherence protects the trial's scientific value and sustains public trust in clinical research.

Other choices, while they may relate to aspects of clinical trials, do not align with the primary goals of monitoring in this context. For instance, maintaining participant blinding (the goal mentioned in option A) is important but is a specific operational detail rather than a core goal of monitoring. Assessing business viability (mentioned in option C) is more relevant to study sponsors and is typically evaluated at the study design phase